• #LGM Pharma is a Dapagliflozin CAS# 461432-26-8 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, delivery, purity, and more.
  • #Questions? Call our customer API support number 1-(800)-881-8210.
  • #LGM Pharma offers this active ingredient but not the finished dosage forms.

Product Details:

  • CAS No: 461432-26-8
  • AHFC code:
  • Synonyms: (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, BMS 512148, BMS-512148, Dapagliflozin, Farxiga, Forxiga, UNII-1ULL0QJ8UC
  • ATC Code: A10BX09
  • Chemical Formula: C21H25O6
  • Molecular Weight: 408.873
  • Assay/Purity: Typically NLT 98%
  • DrugBank:
  • SMILES: [C,H]1([C,H]([C,,H]([C,H](C(O1)c1ccc(c(c1)Cc1ccc(cc1)OCC)Cl)O)O)O)CO
  • InChl: 1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21?/m1/s1
  • PubChem: 9887712
  • IUPAC: D-Glucitol, 1,5-anhydro-1-C-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-, (1S)-

Additional Details

Indication:
Pharmacodynamics:
Mode of Action:
Metabolism:
Toxicity:
General Reference:
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Cost effective materials based on specific requirements
  • Small quantities for initial research and larger development quantities towards product commercialization

 

  • Technical packages, letters of access to filed DMFs
  • Complete assistance in any regulatory filings
  • Top quality GMP certified manufacturers
  • Have necessary regulatory credentials